Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Waste Management Inc.

WM

FAVORABLE

May 27, 2026

Research Conclusion

WM is the highest-quality waste infrastructure company in North America with a durable cornered resource moat of 255 irreplaceable landfills. The FCF inflection thesis (from $2.8B to $4.5B over 3 years) is partially priced at $226, delivering ~10% total expected return (PWFV $245 + 1.7% dividend yield). HOLD at $226; ACCUMULATE below $200; STRONG ADD below $185 where the risk/reward becomes attractive.

Company Overview & Moat Assessment

Waste Management is the largest environmental services company in North America, serving ~22 million customers across 43 states and Canada. Its 255-landfill network—built when new large landfill permits became nearly impossible due to NIMBY and EPA regulations—forms the cornerstone of its moat: a geographically dispersed, irreplicable cornered resource. Collection revenues fund operations while landfill tipping fees generate 30%+ EBITDA margins. The November 2024 acquisition of Stericycle ($7.2B) adds $2.8B revenue in specialized medical/hazardous waste with $250M synergy potential by 2027. Its Renewable Natural Gas platform ($1.4B invested, targeting $500M EBITDA by 2026-end) converts landfill gas into transportation fuel—a high-margin, scalable renewable infrastructure asset. CEO Jim Fish (transitioning to John Morris) has delivered 5-7% organic growth, 50bps/year margin expansion, and 10%+ FCF growth for 8+ consecutive years.

▲ Bull Case

  • Stericycle full synergy delivery and expansion: $250M synergies achieved by FY2027; healthcare waste margins improve 500bps from integration; medical waste commands 20x EBITDA multiple (vs. 13x waste average) → $30-40/share incremental value creation
  • RNG EBITDA $500M achieved and re-rated at infrastructure multiples (20x vs. 13x blended) → $10B embedded RNG value = $25/share uplift; 6 new RNG facilities online FY2026 drive incremental volume upside
  • FCF compounds to $4.5B by FY2028 as CapEx declines from $3.2B to $2.3B post-automation; Stericycle synergies plus organic growth drive EBITDA to $9.8B; FCF at $4.5B × 25x P/FCF = $113B equity value = $287/share

▼ Bear Case

  • Stericycle integration extends through FY2028 with costs of $100-120M/year for 3 years; synergies stall at $150M; FY2027 EPS misses consensus at $7.75 vs. $9.00E → multiple compresses from 25x to 19x → stock reprices to $147-165 with goodwill impairment risk on $5-6B Stericycle intangibles
  • Rate spike above 5% UST causes infrastructure/utility stocks to de-rate; WM repriced at 18-20x (from 25-27x current); at 19x × $9.00 FY2027E = $171 per share = -24% decline despite earnings growth
  • Recession-driven volume softness: industrial waste (20% of revenue) falls 10-15%; pricing power tested; EBITDA growth stalls; FCF guidance misses at $3.2-3.3B vs. $3.75-3.85B guidance → market reprices to $8.00 EPS × 19x = $152/share
Primary Debate on Wall Street

Is the FCF inflection real and sustainable, or does FY2026 guided FCF of $3.75-3.85B reflect working capital timing and CapEx cuts that normalize in FY2027? Bull case: FCF growth is structural (CapEx decline permanent post-automation, Stericycle synergies executable, RNG EBITDA recurring). Bear case: $2.8B to $3.8B in one year includes Q1 2026 working capital tailwinds ($851M = 22% of full-year guide) and integration costs may persist. Our view: the inflection is structural with sustainable FY2027-2028 trajectory of $4.1-4.5B FCF, though FY2026 magnitude may reflect favorable timing.

Top Catalysts
  • Q2 2026 earnings: FCF tracking vs. $3.75-3.85B full-year guidance (65% probability, bull-directional)
  • Stericycle synergy update: $100M FY2025 → $150M+ FY2026 achievement (55% probability, bull-directional)
  • RNG EBITDA $500M announcement by year-end 2026 (45% probability, bull-directional)
  • CEO Morris transition: confirms organic waste and landfill-first capital allocation priorities (certain, neutral to bull)
  • Interest rate spike (10yr UST → 5%+): triggers infrastructure/utility sector de-rating (25% probability, bear-directional)
Top Risks
  • Stericycle integration overrun: costs >$120M/year for 3+ years or >$1B goodwill impairment → downside to $152-165 (25% probability, high severity)
  • Rate-driven multiple compression: 10yr UST spiking above 5% reprices WM at 18-20x vs. current 25-27x → -24% despite earnings growth (25% probability, moderate severity)
  • CEO transition execution: John Morris as COO has lower disruption risk than external hire but capital allocation priorities unconfirmed (10% probability, moderate severity)
  • RNG EBITDA target miss: $300-400M achieved by FY2027 vs. $500M target, reducing bull case but not base case (40% probability, moderate severity)
  • Recession volume softness: industrial waste (20% of revenue) falls 10-15%; EBITDA growth stalls; FCF guidance at $3.2-3.3B vs. $3.75-3.85B (15% probability, moderate severity)

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/WM/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.